Page last updated: 2024-08-25

bay h 2049 and Germinoblastoma

bay h 2049 has been researched along with Germinoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, LW; Chen, A; Collins, JM; Doroshow, JH; Gutierrez, ME; Klecker, RW; Kummar, S; Murgo, AJ	1

Trials

1 trial(s) available for bay h 2049 and Germinoblastoma

Article	Year
Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas. Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Arylamine N-Acetyltransferase; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lymphoma; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Patient Selection; Pharmacogenetics; Quinazolines; Species Specificity; Young Adult	2013

Article

Year

Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas.

Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:4

Topics: Adult; Aged; Antineoplastic Agents; Arylamine N-Acetyltransferase; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lymphoma; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Patient Selection; Pharmacogenetics; Quinazolines; Species Specificity; Young Adult

2013